1. Market Research
  2. > Pharmaceutical

Pharmaceutical Industry Analysis: Latest Market Research & Reports

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
100 votes

Global Pharmaceutical Industry Overview

The pharmaceutical industry consists of companies involved in the research, development and marketing of drugs and biologics.

The pharmaceutical market was valued at $1 trillion in 2013, according to IMS. The market grew at a 4% compound annual growth rate (CAGR) from 2009 to 2013. It grew well in 2010 and 2011 before a decline in growth in 2012 and 2013.

Pharmaceutical Market Value in USD from 2009 to 2013

The pharmaceutical market was driven by a rise in healthcare spending and high growth in both emerging markets and the biologics segment. In 2013, cancer was the largest segment, accounting for 7% ($67 billion) of the global industry. This was closely followed by the pain and diabetes segments with shares of 6% and 5% respectively, according to IMS.

Key Pharmaceutical International Markets

  • North America was the largest market in 2013, with revenues exceeding $340 billion.
  • This was followed by Europe with revenues of $224 billion according to IMS.
  • Emerging countries in Asia and Latin America are forecast to grow rapidly. Increase in spending in these countries will be driven by rising incidence of disease, favorable government policies and improving healthcare infrastructure (and the multiplication of drug stores and pharmacies in large cities.

 Top Pharmaceutical Regional Markets' Growth in 2013

Pharmaceutical Industry Key Players

Novartis was the pharmaceutical market leader in 2013 (thanks to a state-of-the-art drug discovery and development department) with revenues of $51 billion and a market share of 5%. Primary contributors to its sales were the drugs Gilenya and Affinitor. In 2014 Novartis is expected to file 10 new drugs with the U.S.’s Federal Drugs Administration (FDA). Pfizer was close behind Novartis with a 4% shareof the global market according to IMS. Pfizer too is expected to file six new drugs with the FDA in 2014.

The top ten players are forecast to collectively lose share from 35% in 2013 to 30% in 2017, according to IMS. Patent expiries over the next few years will eat into the revenues of most companies during this period.

Sanofi potential loss due to patent expiries is estimated to reach up to $8.1 billion. The company is then followed by Novartis, Roche, Astra-Zeneca and Eli Lilly with respectively potential losses of 7.7, 7.2, 6.7 and 6 billion dollars.  

Pharmaceutical Market Sales Forecast 

Pharmaceutical industry trends show that the global market is set to show steady growth in the next five years at a CAGR of 4-5%. Innovative on-prescritpion drugs and over-the-counter drugs entering the market and biologics such as targeted therapies for cancer will be key in driving growth.

Key Trends and Strategies for Growth in the Pharmaceutical Market

Four trends are shaping pharmaceutical markets.

New Government Policies are Expanding Healthcare Coverage

Expanded patient coverage is a key trend in the pharmaceutical market. China has increased its healthcare spending to $116 billion as part of its latest 12 year plan. India has created a $5 billion policy aimed at providing health services to government hospitals and clinics, especially in the rural areas. The U.S. Affordable Care Act and the U.K. Health and Social Care Act also create opportunities.

The differing nature of the policies means pharmaceutical companies must adapt their marketing strategies for each region or country. A ‘one size fits all’ strategy will no longer work.

Emerging Markets are Improving Healthcare Provision

Improving healthcare provision, increased incidence of chronic diseases, the appearance of safer drug delivery systems and medical tourism are driving pharmaceutical markets in emerging markets. Branded drugs penetration is about 25% (due to the importance of generic drugs) as compared to about 75% in developed economies, according to IMS, giving the potential for expansion in the branded sector. 

Pharmaceuticals companies should focus on these emerging markets. 

Read more »

24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 35 000 reports

Global Pharmaceutical Forecast Statistics

  • August 2016
    6 pages
  • India  


    United States  

View report >

Pharmaceutical Industry in the US

  • September 2016
    72 pages
  • Therapy  



  • United States  

View report >

Pharmaceutical Industry in Europe

  • July 2016
    7 pages
  • Pharmaceutical  

  • Europe  


View report >

The future of the Pharmaceutical Industry in Japan and Asia

  • January 2015
    9 pages
  • Occupational He...  


  • Japan  


View report >

Pharmaceutical Industry in Japan - Forecast

  • July 2016
    10 pages
  • Pharmaceutical  

  • Japan  


View report >

Pharmaceutical Industry in France

  • May 2016
    61 pages
  • France  

    United States  

View report >

Pharmaceutical Industry in Germany

  • March 2016
    11 pages
  • Germany  



View report >

Pharmaceutical Industry in Italy

  • June 2016
    17 pages
  • Pharmaceutical  

  • Italy  


View report >

Pharmaceutical Industry in the UK - Forecast

  • August 2016
    11 pages
  • Pharmaceutical  

  • United Kingdom  

View report >

Pharmaceutical Industry in Canada

  • July 2016
    39 pages
  • Pharmaceutical  

  • Canada  

View report >

About 25 000 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 75 - $ 23 500)

2016 Clinical Chemistry and Immunodiagnostic Analyzers and Reagents: Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies

2016 Clinical Chemistry and Immunodiagnostic Analyzers and Reagents: Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies

  • $ 23 500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $37,500.  DataPack (test volumes, sales forecasts, supplier shares) $23,500. VPGMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities ...

Future Horizons And Growth Strategies In The World Clin ...

August 2016 $ 23 500

Global Clinical Chemistry And Immunodiagnostics Market ...

July 2016 $ 23 500

World Clinical Chemistry And Immunodiagnostic Markets: ...

July 2016 $ 23 500

Immunodiagnostics Market: Us, Europe, Japan--market Ana ...

June 2016 $ 23 500

World Cancer Diagnostics Market Future Horizons And Gro ...

August 2016 $ 21 100

Poc/point-of-care Diagnostic Testing Market New Frontie ...

July 2016 $ 16 600

Immunodiagnostics: Spot Fast-growing Market Segments--t ...

August 2016 $ 15 900

Clinical Chemistry And Immunodiagnostics: A Market In T ...

August 2016 $ 15 900

2016 Europe Clinical Chemistry And Immunodiagnostic Ana ...

September 2016 $ 12 800

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.